1. COVID-19 threatens M&A already in process— Physician survey shows widespread concern about access to testing and medical supplies for COVID— Novartis cancels $1B generics sale — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Hey Compliance, Do you read this board?

Discussion in 'New Haven Pharmaceuticals' started by anonymous, Apr 19, 2016 at 12:58 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Did you ok the whole weekly report on the big Top 25 docs? Cause I'm pretty sure it's not "fair and balanced". I mean, Putting everything in writing every week and emailing it, with the specific doc names and outlining what used car sales tactic we're gonna pull out next? You might want to put some parameters out there and reign that paper trail in. Just sayin'.
     

  2. anonymous

    anonymous Guest

    Time for a whistleblower lawsuit. If your manager has not already done it. Only way to make money off this dog. How about the BS claims that Durlaza = Regular aspirin? Study?